nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial.

MLA

Gridelli, Cesare, et al. “Nab-Paclitaxel/Carboplatin in Elderly Patients with Advanced Squamous Non-Small Cell Lung Cancer: A Retrospective Analysis of a Phase III Trial.” Drug Design, Development and Therapy, vol. 12, May 2018, pp. 1445–51. EBSCOhost, https://doi.org/10.2147/DDDT.S155750.

APA

Gridelli, C., Chen, T., Ko, A., O’Brien, M. E., Ong, T. J., Socinski, M. A., & Postmus, P. E. (2018). nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial. Drug Design, Development and Therapy, 12, 1445–1451. https://doi.org/10.2147/DDDT.S155750

Chicago

Gridelli, Cesare, Tianlei Chen, Amy Ko, Mary E O’Brien, Teng Jin Ong, Mark A Socinski, and Pieter E Postmus. 2018. “Nab-Paclitaxel/Carboplatin in Elderly Patients with Advanced Squamous Non-Small Cell Lung Cancer: A Retrospective Analysis of a Phase III Trial.” Drug Design, Development and Therapy 12 (May): 1445–51. doi:10.2147/DDDT.S155750.